BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 22156331)

  • 1. Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells.
    Zhu M; Chen J; Tan Z; Wang J
    Anesth Analg; 2012 Feb; 114(2):303-9. PubMed ID: 22156331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propofol protects against high glucose-induced endothelial apoptosis and dysfunction in human umbilical vein endothelial cells.
    Zhu M; Wen M; Sun X; Chen W; Chen J; Miao C
    Anesth Analg; 2015 Apr; 120(4):781-9. PubMed ID: 25793913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of reversal of high glucose-induced endothelial nitric oxide synthase uncoupling by tanshinone IIA in human endothelial cell line EA.hy926.
    Zhou ZW; Xie XL; Zhou SF; Li CG
    Eur J Pharmacol; 2012 Dec; 697(1-3):97-105. PubMed ID: 23063542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.
    Cai S; Khoo J; Channon KM
    Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury.
    Zhu M; Chen J; Yin H; Jiang H; Wen M; Miao C
    Vascul Pharmacol; 2014; 61(2-3):72-9. PubMed ID: 24732179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
    Aoki C; Nakano A; Tanaka S; Yanagi K; Ohta S; Jojima T; Kasai K; Takekawa H; Hirata K; Hattori Y
    Int J Cardiol; 2012 Apr; 156(1):55-61. PubMed ID: 21093076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity.
    Li R; Wang WQ; Zhang H; Yang X; Fan Q; Christopher TA; Lopez BL; Tao L; Goldstein BJ; Gao F; Ma XL
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1703-8. PubMed ID: 17895290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell superoxide anion radical generation is not dependent on endothelial nitric oxide synthase-serine 1179 phosphorylation and endothelial nitric oxide synthase dimer/monomer distribution.
    Whitsett J; Martásek P; Zhao H; Schauer DW; Hatakeyama K; Kalyanaraman B; Vásquez-Vivar J
    Free Radic Biol Med; 2006 Jun; 40(11):2056-68. PubMed ID: 16716906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
    Heeba G; Hassan MK; Khalifa M; Malinski T
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells.
    Wang B; Luo T; Chen D; Ansley DM
    Anesth Analg; 2007 Oct; 105(4):1027-33, table of contents. PubMed ID: 17898383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol induces endothelial nitric oxide synthase phosphorylation and activation in human umbilical vein endothelial cells by inhibiting protein kinase C delta expression.
    Wang L; Jiang W
    Eur J Anaesthesiol; 2010 Mar; 27(3):258-64. PubMed ID: 19687739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells.
    Aljofan M; Ding H
    J Cell Physiol; 2010 Mar; 222(3):669-75. PubMed ID: 19950211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
    Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arginine enhances nitrative stress and exacerbates tumor necrosis factor-alpha toxicity to human endothelial cells in culture: prevention by propofol.
    Xia Z; Luo T; Liu HM; Wang F; Xia ZY; Irwin MG; Vanhoutte PM
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):358-67. PubMed ID: 20125033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
    Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
    Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.
    Shinozaki K; Nishio Y; Ayajiki K; Yoshida Y; Masada M; Kashiwagi A; Okamura T
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):122-30. PubMed ID: 17414223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
    Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
    Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17beta-estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease.
    Miyazaki-Akita A; Hayashi T; Ding QF; Shiraishi H; Nomura T; Hattori Y; Iguchi A
    J Pharmacol Exp Ther; 2007 Feb; 320(2):591-8. PubMed ID: 17082313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells.
    Takahashi S; Nakashima Y
    Br J Nutr; 2012 Mar; 107(6):774-80. PubMed ID: 21791144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.